HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Anna Teti Selected Research

AP23236

4/2008Inhibition of protein kinase c-Src as a therapeutic approach for cancer and bone metastases.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Anna Teti Research Topics

Disease

16Bone Resorption
09/2015 - 01/2003
13Osteopetrosis
01/2019 - 10/2003
10Neoplasm Metastasis (Metastasis)
03/2015 - 03/2006
9Breast Neoplasms (Breast Cancer)
03/2022 - 04/2004
8Neoplasms (Cancer)
01/2019 - 01/2002
5Osteoporosis
06/2021 - 06/2009
5Prostatic Neoplasms (Prostate Cancer)
03/2014 - 01/2002
3Fibrosis (Cirrhosis)
01/2022 - 01/2019
3Inflammation (Inflammations)
07/2020 - 11/2006
3Metabolic Bone Diseases (Osteopenia)
01/2018 - 03/2008
3Carcinoma (Carcinomatosis)
04/2009 - 01/2002
2Duchenne Muscular Dystrophy (Muscular Dystrophy, Becker)
01/2022 - 10/2015
2Bone Diseases (Bone Disease)
01/2018 - 01/2012
1Osteolysis
03/2022
1Osteosarcoma (Osteogenic Sarcoma)
12/2021
1Body Weight (Weight, Body)
01/2021
1Acquired Immunodeficiency Syndrome (AIDS)
01/2021
1Diastrophic dysplasia
01/2021
1Gliosis
01/2019
1Inborn Genetic Diseases (Disease, Hereditary)
01/2018
1Cognitive Dysfunction
10/2015
1Paralysis (Palsy)
02/2015
1Muscular Dystrophies (Muscular Dystrophy)
02/2015
1Chronic recurrent multifocal osteomyelitis
01/2014
1Poikiloderma with Neutropenia
01/2012
1Primary Myelofibrosis (Myelosclerosis)
01/2010
1Hypocalcemia
06/2009
1Secondary Hyperparathyroidism
06/2009
1Melanoma (Melanoma, Malignant)
04/2009

Drug/Important Bio-Agent (IBA)

8Proteins (Proteins, Gene)FDA Link
07/2020 - 01/2002
5Conditioned Culture MediaIBA
09/2017 - 04/2004
4LigandsIBA
01/2021 - 08/2007
4CytokinesIBA
09/2017 - 07/2004
3Oxygen (Dioxygen)IBA
09/2017 - 11/2012
3Interleukin-6 (Interleukin 6)IBA
08/2011 - 07/2006
3Alkaline PhosphataseIBA
01/2010 - 01/2003
2Lipocalin-2IBA
01/2022 - 01/2018
2Biological ProductsIBA
01/2021 - 09/2013
2InflammasomesIBA
07/2020 - 01/2014
2Botulinum Toxins (Botulinum Toxin)IBA
01/2019 - 02/2015
2Type A Botulinum Toxins (Botox)FDA Link
01/2019 - 02/2015
2Doxorubicin (Adriamycin)FDA LinkGeneric
03/2015 - 04/2004
2IntegrinsIBA
08/2014 - 05/2008
2CalciumIBA
04/2014 - 01/2012
2beta-apocarotenoid-14',13'-dioxygenase (ADO)IBA
03/2014 - 10/2003
2EnzymesIBA
01/2012 - 04/2006
2MineralsIBA
08/2011 - 07/2004
2Receptor Activator of Nuclear Factor-kappa B (TRANCE-R)IBA
08/2010 - 05/2008
2Phosphotransferases (Kinase)IBA
04/2009 - 07/2006
2Protein Kinase CIBA
04/2008 - 07/2006
1Cadherins (E-Cadherin)IBA
03/2022
1Monoclonal AntibodiesIBA
01/2022
1Immunoglobulin G (IgG)IBA
01/2022
1Methylnitronitrosoguanidine (MNNG)IBA
12/2021
1Sulfates (Sulfates, Inorganic)IBA
01/2021
1Acetylcysteine (Siran)FDA LinkGeneric
01/2021
1ChloridesIBA
01/2021
1Peroxisome Proliferator-Activated Receptors (PPAR)IBA
01/2021
1Amyloid (Amyloid Fibrils)IBA
01/2019
1bone resorption factorIBA
01/2019
1Biomarkers (Surrogate Marker)IBA
09/2017
1Creatine Kinase (Creatine Phosphokinase)IBA
10/2015
1Purinergic Receptors (Receptors, Purine)IBA
10/2015
1Hydrochloric Acid (Hydrogen Chloride)FDA Link
09/2015
1AntiportersIBA
09/2015
1Small Interfering RNA (siRNA)IBA
09/2015
1chondroadherinIBA
03/2015
1Nitric Oxide Synthase (NO Synthase)IBA
08/2014
1Cyclic PeptidesIBA
08/2014
1Vacuolar Proton-Translocating ATPases (V-Type ATPase)IBA
04/2014
1Lactic Acid (Lactate)FDA LinkGeneric
03/2014
1NLR ProteinsIBA
01/2014
1Messenger RNA (mRNA)IBA
01/2014
1PlasticsIBA
06/2012
1Metalloproteases (Metalloproteinases)IBA
08/2010
1Basigin (Extracellular Matrix Metalloproteinase Inducer (EMMPRIN))IBA
08/2010
1Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)IBA
08/2010
1Membrane Glycoproteins (Membrane Glycoprotein)IBA
08/2010
1Matrix Metalloproteinases (MMPs)IBA
08/2010
1Insulin (Novolin)FDA Link
07/2010
1OsteocalcinIBA
07/2010
1Glucose (Dextrose)FDA LinkGeneric
07/2010
1salicylhydroxamic acid (SHAM)IBA
01/2010
1AcidsIBA
06/2009
1Cholecystokinin B ReceptorIBA
06/2009
1Protein-Tyrosine Kinases (Tyrosine Kinase)IBA
06/2009
1Proton Pumps (Proton Pump)IBA
06/2009
1EphrinsIBA
05/2009
1EphA2 ReceptorIBA
04/2009
1GTP Phosphohydrolases (GTPases)IBA
04/2009
1Tyrosine (L-Tyrosine)FDA Link
04/2009
1Cytoplasmic and Nuclear Receptors (Nuclear Receptors)IBA
05/2008
1RANK LigandIBA
05/2008
1OsteoprotegerinIBA
05/2008
1Cell Surface ReceptorsIBA
05/2008
1AP22408IBA
04/2008

Therapy/Procedure

5Therapeutics
01/2018 - 07/2006
1Bed Rest (Bedrest)
06/2021
1Injections
01/2021
1Drug Therapy (Chemotherapy)
03/2015